Financial News
Latest News about CVAC
Recent news which mentions CVAC
Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg
February 26, 2021
From Benzinga
Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses
February 25, 2021
From Benzinga
Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain
February 25, 2021
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters
February 18, 2021
From Benzinga
Shortage Of Giant Sterile Liners Threatens Global Vaccines Rollout: FT
February 17, 2021
From Benzinga
COVID-19 Vaccine Updates: US Strikes 100M-Dose Supply Deals With Moderna, Pfizer, EU Starts Rolling Review Of CureVac Vaccine
February 12, 2021
From Benzinga
Merck In Talks To Possibly Produce COVID-19 Shots: WSJ
February 11, 2021
From Benzinga
J&J’s COVID-19 vaccine candidate sparks hopes for faster recovery, just as daily deaths spike above 5,000 in the U.S.
February 05, 2021
From MarketWatch
CureVac Shares Gain After UK Backs Company's Vaccine Development Efforts For COVID-19 Variants
February 05, 2021
From Benzinga
CureVac Expands Early-Stage Study Evaluating CV8102 In Skin Cancer
February 04, 2021
Tickers
CVAC
From Benzinga
GlaxoSmithKline Shares Slip On Weaker Profit Forecast For 2021, Plans To Cut Dividend
February 03, 2021
From Benzinga
From MarketWatch
From MarketWatch
Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more
February 03, 2021
From MarketWatch
The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision
February 03, 2021
From Benzinga
From MarketWatch
A Peek Into The Markets: US Stock Futures Up; Alphabet, Amazon Report Upbeat Earnings
February 03, 2021
From Benzinga
From Benzinga
From MarketWatch
102 Biggest Movers From Yesterday
February 02, 2021
From Benzinga
70 Stocks Moving In Monday's Mid-Day Session
February 01, 2021
From Benzinga
BioNTech-Pfizer partnership pledges 75 million more vaccine doses to help ease the EU bloc’s shortage
February 01, 2021
From MarketWatch
2 Best Pharma Stocks to Buy Right Now
January 27, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
8 Stocks Moving In Monday's After-Hours Session
January 25, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
